Panacea-Serum Team Up To Take Six-In-One Vaccine Global

Panacea Biotec has allied with the world’s largest-vaccine maker, the Serum Institute of India, to ramp up production of a six-in-one jab aimed at preventing killer diseases like polio and diphtheria and target a global market estimated to be worth over $1.25bn annually.

Hand Shake
PANACEA AND SERUM INSTITUTE HAVE JOINED HANDS FOR THE HEXAVALENT VACCINE

More from Business

More from Scrip